Sector: health
Conviction from: NASDAQ
52-week range: 29.4560.91
Veracyte is a diagnostics company offering genomic tests and software that help physicians assess cancer risk and guide treatment across thyroid, lung, prostate, and other indications.
3 tracked filer(s) hold this · 0 opened, 1 added, 2 trimmed in 30-JUN-2026
Aggregate 13FScore 62 — mean of 3 scored holder(s) · buyers (new/add) avg 76. Higher = the smart money in this name has the better track record.
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
1 disclosed trade(s) by 1 filer(s).